Altris AI is a unique AI-powered, web-based platform for OCT exam interpretation that was developed to empower optometrists. It helps to create an efficient patient workflow and support diagnostic decision-making. Altris AI identifies over 70 pathologies and biomarkers on the OCT scans including GA, wet and dry AMD, DR, and others. Our Glaucoma Early Risk and Pathology Progression Tracking modules allow optometrists to assess the early risk of glaucoma and the effectiveness of treatment. Drop by to see how Altris AI can enhance your patient care and register for a 1-month free trial.
Address
ChicagoUnited States
Contact Exhibitor
Products
-
Altris AI, a pioneering force in artificial intelligence for OCT scan analysis, has unveiled additional quantification features for Fluids and Geographic Atrophy (GA) tracking on its web platform. Alt ...
-
Altris AI is an artificial intelligence platform for OCT analysis that detects the widest range of retina pathologies and biomarkers on the market - more than 70. The Altris AI platform empowers Optom ...
-
To address the challenge of a high rate of false positive referrals and delayed or missed detection of glaucoma, Altris AI has introduced its Advanced Optic Disc (OD) Analysis, building on its earlier ...
Videos
-
Altris AI, AI for OCT scan analysis that detects the widest range of retina pathologies, signs, and biomarkers (over 70), launches an advanced glaucoma Optic Disc Analysis module.
News
-
Altris AI now launches major updates before 100% Optical: Glaucoma Optic Disc Analysis module along with Fluids and Geographic Atrophy (GA) quantification and tracking functionalities.